Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welt

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beamS Ruan, J A O'Donoghue, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograftE C Barendswaard, J A O'Donoghue, S M Larson, et al.
British Journal of Cancer|March 20, 2003
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapyP M Deckert, C Renner, L S Cohen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Localization of complement-fixing cytotoxic monoclonal antibodies to subcutaneous tumors and liver metastases in a syngeneic immunocompetent rat colon carcinoma modelK P O'Boyle, M J Mattes, E R Sigurdson, et al.
Diseases of the Colon and Rectum|September 28, 1998
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastasesA M Cohen, P Garin-Chesa, M Hanson, et al.
Hybridoma|December 1, 1996
Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigensK P O'Boyle, A L Markowitz, M Khorshidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibodyF Daghighian, E Barendswaard, S Welt, et al.
International Journal of Cancer|January 21, 1991
Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancerM H Schuessler, S Pintado, S Welt, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectorsJ E Surfus, J A Hank, E Oosterwijk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2001
Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograftE C Barendswaard, J L Humm, J A O'Donoghue, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 18, 2000
Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beamS Ruan, J A O'Donoghue, S M Larson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograftE C Barendswaard, J A O'Donoghue, S M Larson, et al.
British Journal of Cancer|March 20, 2003
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapyP M Deckert, C Renner, L S Cohen, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Localization of complement-fixing cytotoxic monoclonal antibodies to subcutaneous tumors and liver metastases in a syngeneic immunocompetent rat colon carcinoma modelK P O'Boyle, M J Mattes, E R Sigurdson, et al.
Diseases of the Colon and Rectum|September 28, 1998
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastasesA M Cohen, P Garin-Chesa, M Hanson, et al.
Hybridoma|December 1, 1996
Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigensK P O'Boyle, A L Markowitz, M Khorshidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibodyF Daghighian, E Barendswaard, S Welt, et al.
International Journal of Cancer|January 21, 1991
Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancerM H Schuessler, S Pintado, S Welt, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectorsJ E Surfus, J A Hank, E Oosterwijk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2001
Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograftE C Barendswaard, J L Humm, J A O'Donoghue, et al.
Pageof 7